Revasol Tussin
- Product NDC
- 84379-313
- 11-digit product format
- 843790313
- Labeler code
- 84379
- Product ID
- 84379-313_4b84bd2e-c45a-9c59-e063-6294a90ad1e5
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Rnv LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2024-08-19
- Substance
- GUAIFENESIN
- Active strength
- 200 mg/10mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Revasol Tussin
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 200 mg/10mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1606850 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f66dc593-9023-40e8-9cc3-0380b04b4305 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84379-313-04 | Revasol Tussin | 118 mL in 1 BOTTLE | LIQUID | 118 | 4 | |
| 84379-313-16 | Revasol Tussin | 474 mL in 1 BOTTLE | LIQUID | 474 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zicam Extreme Congestion Relief | OXYMETAZOLINE HYDROCHLORIDE | Church & Dwight Co., Inc. | ccada339-656c-a461-e053-2a95a90a3479 | 2025-12-31 | Warnings | M012 |
| ED A-HIST DM | DEXTROMETHORPHAN HYDROBROMIDE, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HYDROCHLORIDE | EDWARDS PHARMACEUTICALS, INC. | e0e2b117-62bc-4132-9f7c-fe2a912052b1 | 2025-12-31 | Warnings | M012 |
| Bio-Z-Cough | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | Advanced Generic Corporation | 05e70eab-1467-4b09-991e-ef03f222e021 | 2025-12-31 | Warnings | M012 |
| Altipres-B | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | Alternative Pharmacal Corporation | fd00c41d-0580-4177-afaa-60bb12ca5a09 | 2025-12-31 | Warnings | M012 |
| Ninjacof-D | CHLOPHEDIANOL HYDROCHLORIDE, PYRILAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE | Centurion Labs, LLC | 5188aa20-41f1-4998-81e1-f4de055874bc | 2025-12-31 | Warnings | M012 |
| Llorens Care Tussin DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Llorens Pharmaceutical International Division, Inc. | 4743e562-1217-50ab-e063-6394a90af88d | 2025-12-31 | Warnings | M012 |
| Llorens Care Tussin | GUAIFENESIN | Llorens Pharmaceutical International Division, Inc. | 474459c1-bfd7-dec7-e063-6394a90ac18d | 2025-12-31 | Warnings | M012 |
| Geri Care Tussin CF Max | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN | GERI-CARE PHARMACEUTICAL CORP | 4744669c-7f33-e35f-e063-6394a90a79b7 | 2025-12-31 | Warnings | M012 |
| Geri-Tussin | GUAIFENESIN | Geri-Care Pharmaceuticals, Corp | 65545ca3-4e93-4b59-9e17-4742e086e8e7 | 2025-12-31 | Warnings | M012 |
| GeriCare Tussin DM Max | DEXTROMETHORPHAN HBR, GUAIFENESIN | GERI-CARE PHARMACEUTICALS, CORP | 47451cd8-7aab-90e2-e063-6394a90ad1b7 | 2025-12-31 | Warnings | M012 |
| Curewell Tussin | GUAIFENESIN | RMT HEALTH LLC | 47455587-5074-e70d-e063-6294a90a78bb | 2025-12-31 | Warnings | M012 |
| Menthol Cough Drops | MENTHOL | Bestco Inc. | 77e25027-3c96-21fa-e053-2991aa0a1f31 | 2025-12-31 | Warnings | M012 |
| Puregen Labs Allergy Relief | DIPHENHYDRAMINE HCL | Advanced Rx LLC | 4745d4f9-bbdf-a4a6-e063-6294a90a15b2 | 2025-12-31 | Warnings | M012 |
| Allergy Relief | DIPHENHYDRAMINE HCL | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | 2a46ea9b-29e9-5197-e063-6394a90abc73 | 2025-12-31 | Warnings | M012 |
| Cherry Cough Drops | MENTHOL | Bestco Inc. | 77e50410-306d-b2fb-e053-2a91aa0af3c5 | 2025-12-31 | Warnings | M012 |
| Allergy Relief | DIPHENHYDRAMINE HCL | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | e086a6d2-f664-454e-9524-f656bfbf45df | 2025-12-31 | Warnings | M012 |
| Cherry Cough Drops | MENTHOL | Bestco Inc. | 77f45efb-8ee0-1186-e053-2991aa0a9884 | 2025-12-31 | Warnings | M012 |
| Conex Pediatric | DEXBROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL | Llorens Pharmaceutical International Division | 2a46af43-ef36-e14e-e063-6394a90a8285 | 2025-12-31 | Warnings | M012 |
| Conex | DEXBROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL | Llorens Pharmaceutical International Division | 2a343656-ac6d-8b20-e063-6294a90ab319 | 2025-12-31 | Warnings | M012 |
| Dologesic NF | ACETAMINOPHEN, DEXBROMPHENIRAMINE MALEATE | Llorens Pharmaceutical International Division | 974fc0d5-7a99-46fb-af38-b91240f728fa | 2025-12-31 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1606850 | guaiFENesin 200 MG in 10 mL Oral Suspension | PSN | f66dc593-9023-40e8-9cc3-0380b04b4305 | 4 |
| 1606850 | guaifenesin 20 MG/ML Oral Suspension | SCD | f66dc593-9023-40e8-9cc3-0380b04b4305 | 4 |
| 1606850 | guaifenesin 200 MG per 10 ML Oral Suspension | SY | f66dc593-9023-40e8-9cc3-0380b04b4305 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 84379-313-04 | 84379031304 | 118 mL in 1 BOTTLE (84379-313-04) | 118 ml | 2024-08-19 | No | No | Current |
| 84379-313-16 | 84379031316 | 474 mL in 1 BOTTLE (84379-313-16) | 474 ml | 2025-09-01 | No | No | Current |